Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.

about

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)

P2860

Q58726261-010E0F41-45D4-4C7F-91DF-262B079450D6

P2860

Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.

Item

http://www.wikidata.org/entity/Q45325816

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Risk factors for biopsy-proven ...... eterans Health Administration.

@en

Risk factors for biopsy-proven ...... eterans Health Administration.

@nl

type

Item

label

Risk factors for biopsy-proven ...... eterans Health Administration.

@en

Risk factors for biopsy-proven ...... eterans Health Administration.

@nl

altLabel

Risk factors for biopsy-proven ...... Veterans Health Administration

@en

prefLabel

Risk factors for biopsy-proven ...... eterans Health Administration.

@en

Risk factors for biopsy-proven ...... eterans Health Administration.

@nl

P1476

Risk factors for biopsy-proven ...... Veterans Health Administration

@en

P2093

B Han

http://www.w3.org/2001/XMLSchema#string

C A Moylan

http://www.w3.org/2001/XMLSchema#string

D Provenzale

http://www.w3.org/2001/XMLSchema#string

E J Gifford

http://www.w3.org/2001/XMLSchema#string

L M Glass

http://www.w3.org/2001/XMLSchema#string

M J Turner

http://www.w3.org/2001/XMLSchema#string

R McNeil

http://www.w3.org/2001/XMLSchema#string

S S Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Nonalcoholic fatty liver disease: a systematic review

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

P304

268-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.14411

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Y A Patel

Christine M Hunt

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29115682

http://www.w3.org/2001/XMLSchema#string

P921

veteran

P932

5861349

http://www.w3.org/2001/XMLSchema#string

Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.

about

P2860

P2860

Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932